Related Experiment Videos
beta-Mannosidase in human leukocytes and fibroblasts
Journal of Inherited Metabolic Disease
|January 1, 1984
Summary
Beta-mannosidase enzyme activity in human cells peaks at pH 4.0-4.5. This enzyme activity is significantly lower in I-cell disease patients and in goats compared to humans.
Area of Science:
- Biochemistry
- Enzymology
- Human Genetics
Background:
- Beta-mannosidase is a key enzyme involved in glycoprotein metabolism.
- Deficiency in beta-mannosidase activity is associated with specific lysosomal storage disorders.
- Understanding enzyme kinetics and species-specific activity is crucial for disease research.
Purpose of the Study:
- To characterize the pH optimum of beta-mannosidase in human leukocytes and fibroblasts.
- To investigate beta-mannosidase activity in the context of I-cell disease.
- To compare human beta-mannosidase activity with that of the goat.
Main Methods:
- Enzyme activity assays were performed on human leukocytes and fibroblasts.
- pH optima were determined for beta-mannosidase.
- Enzyme activity levels were compared between healthy individuals, I-cell disease patients, and goats.
Main Results:
- Human beta-mannosidase exhibited a unimodal pH optimum between 4.0 and 4.5.
- Markedly reduced beta-mannosidase activity was observed in I-cell disease.
- Human fibroblasts showed approximately ten times higher beta-mannosidase activity than goat fibroblasts.
Conclusions:
- The optimal pH for human beta-mannosidase activity is established.
- I-cell disease is characterized by significantly impaired beta-mannosidase function.
- Comparative analysis highlights species-specific differences in beta-mannosidase activity, relevant to deficiency disease studies.